Edwards Lifesciences Corporation Proceeds from Sale and Maturity of Held-to-maturity Securities
Edwards Lifesciences Corporation (EW) reported Proceeds from Sale and Maturity of Held-to-maturity Securities of $18.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities · last filed 2026-08-04
- Edwards Lifesciences Corporation proceeds from sale and maturity of held-to-maturity securities for the quarter ending 2026-06-30 was $5.90M, a 58.74% decline year-over-year.
- Edwards Lifesciences Corporation proceeds from sale and maturity of held-to-maturity securities for the quarter ending 2026-03-31 was $12.50M, a 29.38% decline year-over-year.
- Edwards Lifesciences Corporation proceeds from sale and maturity of held-to-maturity securities for the quarter ending 2025-12-31 was $7.90M, a 11.27% increase year-over-year.
- Edwards Lifesciences Corporation proceeds from sale and maturity of held-to-maturity securities for the quarter ending 2025-09-30 was $22.20M, a 11.90% decline year-over-year.
- Edwards Lifesciences Corporation proceeds from sale and maturity of held-to-maturity securities for fiscal 2025 was $62.10M, a 8.00% increase from fiscal 2024.
- Edwards Lifesciences Corporation proceeds from sale and maturity of held-to-maturity securities for fiscal 2024 was $57.50M, a 41.27% decline from fiscal 2023.
- Edwards Lifesciences Corporation proceeds from sale and maturity of held-to-maturity securities for fiscal 2023 was $97.90M, a 76.66% decline from fiscal 2022.
- Edwards Lifesciences Corporation proceeds from sale and maturity of held-to-maturity securities for fiscal 2022 was $419.50M, a 203.99% increase from fiscal 2021.
| Period end | Proceeds from Sale and Maturity of Held-to-maturity Securities 3 month | Proceeds from Sale and Maturity of Held-to-maturity Securities 6 month | Proceeds from Sale and Maturity of Held-to-maturity Securities 9 month | Proceeds from Sale and Maturity of Held-to-maturity Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $18.40M 10-Q · filed 2026-08-04 | $26.30M derived: sum of 3 quarters · filed 2026-08-04 | $48.50M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $12.50M 10-Q · filed 2026-05-06 | $20.40M derived: sum of 2 quarters · filed 2026-05-06 | $42.60M derived: sum of 3 quarters · filed 2026-05-06 | $56.90M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $30.10M derived: sum of 2 quarters · filed 2026-02-25 | $44.40M derived: sum of 3 quarters · filed 2026-08-04 | $62.10M 10-K · filed 2026-02-25 |
| 2025-09-30 | $22.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $36.50M derived: sum of 2 quarters · filed 2026-08-04 | $54.20M 10-Q · filed 2025-11-05 | $61.30M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $14.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $32.00M 10-Q · filed 2026-08-04 | $39.10M derived: sum of 3 quarters · filed 2026-08-04 | $64.30M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $17.70M 10-Q · filed 2026-05-06 | $24.80M derived: sum of 2 quarters · filed 2026-05-06 | $50.00M derived: sum of 3 quarters · filed 2026-05-06 | $65.90M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $32.30M derived: sum of 2 quarters · filed 2026-02-25 | $48.20M derived: sum of 3 quarters · filed 2026-02-25 | $57.50M 10-K · filed 2026-02-25 |
| 2024-09-30 | $25.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $41.10M derived: sum of 2 quarters · filed 2025-11-05 | $50.40M 10-Q · filed 2025-11-05 | $56.80M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $15.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $25.20M 10-Q · filed 2025-08-06 | $31.60M derived: sum of 3 quarters · filed 2026-02-25 | $39.60M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $9.30M 10-Q · filed 2025-05-06 | $15.70M derived: sum of 2 quarters · filed 2026-02-25 | $23.70M derived: sum of 3 quarters · filed 2026-02-25 | $26.70M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $14.40M derived: sum of 2 quarters · filed 2026-02-25 | $17.40M derived: sum of 3 quarters · filed 2026-02-25 | $97.90M 10-K · filed 2026-02-25 |
| 2023-09-30 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $11.00M derived: sum of 2 quarters · filed 2024-11-06 | $91.50M 10-Q · filed 2024-11-06 | $186.50M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $83.50M 10-Q · filed 2024-07-31 | $178.50M derived: sum of 3 quarters · filed 2025-02-28 | $225.50M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $80.50M 10-Q · filed 2024-04-29 | $175.50M derived: sum of 2 quarters · filed 2025-02-28 | $222.50M derived: sum of 3 quarters · filed 2025-02-28 | $370.00M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $95.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $142.00M derived: sum of 2 quarters · filed 2025-02-28 | $289.50M derived: sum of 3 quarters · filed 2025-02-28 | $419.50M 10-K · filed 2025-02-28 |
| 2022-09-30 | $47.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $194.50M derived: sum of 2 quarters · filed 2023-10-27 | $324.50M 10-Q · filed 2023-10-27 | $392.50M derived: sum of 4 quarters · filed 2024-02-12 |
| 2022-06-30 | $147.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $277.50M 10-Q · filed 2023-07-28 | $345.50M derived: sum of 3 quarters · filed 2024-02-12 | $365.50M derived: sum of 4 quarters · filed 2024-02-12 |
| 2022-03-31 | $130.00M 10-Q · filed 2023-04-28 | $198.00M derived: sum of 2 quarters · filed 2024-02-12 | $218.00M derived: sum of 3 quarters · filed 2024-02-12 | $218.00M derived: sum of 4 quarters · filed 2024-02-12 |
| 2021-12-31 | $68.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $88.00M derived: sum of 2 quarters · filed 2024-02-12 | $88.00M derived: sum of 3 quarters · filed 2024-02-12 | $138.00M 10-K · filed 2024-02-12 |
| 2021-09-30 | $20.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $20.00M derived: sum of 2 quarters · filed 2022-10-28 | $70.00M 10-Q · filed 2022-10-28 | $70.00M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $50.00M 10-Q · filed 2022-07-29 | $50.00M derived: sum of 3 quarters · filed 2023-02-13 | $50.00M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-03-31 | $50.00M 10-Q · filed 2022-04-28 | $50.00M derived: sum of 2 quarters · filed 2023-02-13 | $50.00M derived: sum of 3 quarters · filed 2023-02-13 | $162.00M derived: sum of 4 quarters · filed 2023-02-13 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $0.00 derived: sum of 2 quarters · filed 2023-02-13 | $112.00M derived: sum of 3 quarters · filed 2023-02-13 | $212.20M 10-K · filed 2023-02-13 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $112.00M derived: sum of 2 quarters · filed 2021-10-29 | $212.20M 10-Q · filed 2021-10-29 | $212.20M derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-06-30 | $112.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $212.20M 10-Q · filed 2021-07-30 | $212.20M derived: sum of 3 quarters · filed 2022-02-14 | $212.20M derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-03-31 | $100.20M 10-Q · filed 2021-04-28 | $100.20M derived: sum of 2 quarters · filed 2022-02-14 | $100.20M derived: sum of 3 quarters · filed 2022-02-14 | $130.20M derived: sum of 4 quarters · filed 2022-02-14 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $0.00 derived: sum of 2 quarters · filed 2022-02-14 | $30.00M derived: sum of 3 quarters · filed 2022-02-14 | $50.00M 10-K · filed 2022-02-14 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | $30.00M derived: sum of 2 quarters · filed 2020-10-26 | $50.00M 10-Q · filed 2020-10-26 | $240.00M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $30.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-27 | $50.00M 10-Q · filed 2020-07-27 | $240.00M derived: sum of 3 quarters · filed 2021-02-12 | $288.60M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $20.00M 10-Q · filed 2020-04-28 | $210.00M derived: sum of 2 quarters · filed 2021-02-12 | $258.60M derived: sum of 3 quarters · filed 2021-02-12 | $359.60M derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $190.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $238.60M derived: sum of 2 quarters · filed 2021-02-12 | $339.60M derived: sum of 3 quarters · filed 2021-02-12 | $578.10M 10-K · filed 2021-02-12 |
| 2018-09-30 | $48.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $149.60M derived: sum of 2 quarters · filed 2019-10-25 | $388.10M 10-Q · filed 2019-10-25 | $709.80M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-06-30 | $101.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | $339.50M 10-Q · filed 2019-07-26 | $661.20M derived: sum of 3 quarters · filed 2020-02-14 | $762.20M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-03-31 | $238.50M 10-Q · filed 2019-04-26 | $560.20M derived: sum of 2 quarters · filed 2020-02-14 | $661.20M derived: sum of 3 quarters · filed 2020-02-14 | $663.70M derived: sum of 4 quarters · filed 2020-02-14 |
| 2017-12-31 | $321.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $422.70M derived: sum of 2 quarters · filed 2020-02-14 | $425.20M derived: sum of 3 quarters · filed 2020-02-14 | $654.70M 10-K · filed 2020-02-14 |
| 2017-09-30 | $101.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $103.50M derived: sum of 2 quarters · filed 2018-10-26 | $333.00M 10-Q · filed 2018-10-26 | $556.80M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $232.00M 10-Q · filed 2018-07-27 | $455.80M derived: sum of 3 quarters · filed 2019-02-15 | $737.20M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | $229.50M 10-Q · filed 2018-04-27 | $453.30M derived: sum of 2 quarters · filed 2019-02-15 | $734.70M derived: sum of 3 quarters · filed 2019-02-15 | $827.00M derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | $223.80M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $505.20M derived: sum of 2 quarters · filed 2019-02-15 | $597.50M derived: sum of 3 quarters · filed 2019-02-15 | $852.50M 10-K · filed 2019-02-15 |
| 2016-09-30 | $281.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $373.70M derived: sum of 2 quarters · filed 2017-10-27 | $628.70M 10-Q · filed 2017-10-27 | $753.70M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $92.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $347.30M 10-Q · filed 2017-07-28 | $472.30M derived: sum of 3 quarters · filed 2018-02-16 | $1.04B derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $255.00M 10-Q · filed 2017-04-28 | $380.00M derived: sum of 2 quarters · filed 2018-02-16 | $952.50M derived: sum of 3 quarters · filed 2018-02-16 | $1.18B derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $125.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $697.50M derived: sum of 2 quarters · filed 2018-02-16 | $929.20M derived: sum of 3 quarters · filed 2018-02-16 | $1.26B 10-K · filed 2018-02-16 |
| 2015-09-30 | $572.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $804.20M derived: sum of 2 quarters · filed 2016-10-28 | $1.14B 10-Q · filed 2016-10-28 | $1.83B derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $231.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $562.60M 10-Q · filed 2016-07-29 | $1.26B derived: sum of 3 quarters · filed 2017-02-17 | $1.58B derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $330.90M 10-Q · filed 2016-04-29 | $1.03B derived: sum of 2 quarters · filed 2017-02-17 | $1.35B derived: sum of 3 quarters · filed 2017-02-17 | $1.65B derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $698.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $1.02B derived: sum of 2 quarters · filed 2017-02-17 | $1.31B derived: sum of 3 quarters · filed 2017-02-17 | $1.61B 10-K · filed 2017-02-17 |
| 2014-09-30 | $317.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $615.80M derived: sum of 2 quarters · filed 2015-10-29 | $912.60M 10-Q · filed 2015-10-29 | $1.14B derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | $298.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $594.90M 10-Q · filed 2015-07-29 | $818.50M derived: sum of 3 quarters · filed 2016-02-19 | $890.40M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | $296.80M 10-Q · filed 2015-04-29 | $520.40M derived: sum of 2 quarters · filed 2016-02-19 | $592.30M derived: sum of 3 quarters · filed 2016-02-19 | $678.00M derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | $223.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $295.50M derived: sum of 2 quarters · filed 2016-02-19 | $381.20M derived: sum of 3 quarters · filed 2016-02-19 | $526.40M 10-K · filed 2016-02-19 |
| 2013-09-30 | $71.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $157.60M derived: sum of 2 quarters · filed 2014-10-31 | $302.80M 10-Q · filed 2014-10-31 | |
| 2013-06-30 | $85.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $230.90M 10-Q · filed 2014-08-04 | ||
| 2013-03-31 | $145.20M 10-Q · filed 2014-05-02 | |||
| 2012-12-31 | $662.30M 10-K · filed 2015-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |